services

demands

behavior

Location: Policy & Industy - policy
I have question
NHFPC abrogates the third classification technology accreditation

NHFPC abrogates the third classification technology accreditation for its clinical application. The medical institutes are prohibited to apply clinical operation of technology that has vital safety issues, and debating ethic issues and that is clearly forbidden or be eliminated


The technologies that has high difficulties, risks, and that requires high technical staffs are limited to use. For the medical institutes that plan carry out the technology operation, they should obtain the accreditation from NHFPC. For the medical institutes that have already gotten the accreditation from former health ministry, they should fill record in the NHFPC. 


After the abrogation of third classification technology accreditation, the medical institutes take the main responsibility and liability for its clinical use and managementFor more detailed information, please visit the Chinese version website of NHFPC: http://www.nhfpc.gov.cn/yzygj/s3585/201507/c529dd6bb8084e09883ae417256b3c49.shtml?WebShieldSessionVerify=SBGnACn6BB0AKset114a

  • 政府机构
  • 分支机构
  • 会员单位
  • 友情链接
  • 国家尾数健康委
  • 国家药监局
  • 国家医保局
  • 科技部
  • 发改委
  • 民政部
  • 中国食品药品检定研究院
  • 国家药品审评中心
  • 中国生物技术发展中心
  • 分支机构
  • 会员单位
  • 友情链接

2003-2012©

China Medicinal Biotech Association

All Rights Reserved

phome: +86 10 62115986,62126275,67044735,67044736

Fax: +86 10 62115976

E-mail:cmba@cmba.org.cn